The Ministry of Trade, Industry and Energy announced on May 2 that exports from the domestic biotech and healthcare sectors totaled US$1.26 billion last month, the highest April figure and up 14.2 percent from a year ago.Last month, exports from the sectors increased year on year for the fifth conse
The author is an analyst of NH Investment & Securities. He can be reached at esshim@nhqv.com. -- Ed. H.PIO specializes in health functional food manufacturing and branding. Premium brand Denps is expanding its product portfolio focusing on vitamin products. In addition to its solid main business, co
The author is an analyst of NH Investment & Securities. He can be reached at pk.park@nhqv.co. -- Ed. Hanmi Pharm posted consolidated 1Q22 sales of W321.1bn and OP of W38.7bn, in line with our estimates, thanks to Beijing Hanmi and business normalization amid the easing of the Covid-19 pandemic. Glob
The Presidential Transition Committee said that the new South Korean government is planning to come up with a 6G communications prototype in 2026 with the technology expected to be commercialized between 2028 and 2030.“When it comes to future economic growth drivers, the current government is focusi
Korea Hydro & Nuclear Power (KHNP) has submitted a proposal for a nuclear power plant project to Poland. KHNP officials will meet with Adam Guibourgé-Czetwertyński, undersecretary of state at the Polish Ministry of Climate and Environment, on April 21 to submit a project proposal. The Polish ministr
Kolon Life Science has licensed out its osteoarthritis cell gene treatment TG-C, also known as Invossa, to a new biotech company in Singapore in a deal worth up to 720 billion won.The company announced on April 13 that it has signed a 723.4 billion won (US$587.18 million) technology export contract
HanAll Biopharma and Daewoong Pharmaceutical announced on April 11 an expansion of their open collaboration strategy by investing in Turn Biotechnologies, a Silicon Valley based company focused on developing novel mRNA medicines. The companies are supporting Turn Bio’s continued development of a hig
Cell-gene therapeutics (CGTs) are emerging in the biotech industry and an increasing number of companies are focusing on the market segment.The Life Science Fund of Samsung recently decided to invest in Jaguar Gene Therapy. In the biotech fund, Samsung C&T, Samsung Biologics and Samsung Venture Inve
The Bank of Korea said in its report on March 30 that raw material procurement risks triggered by the war in Ukraine and China’s rise are currently the biggest concerns for South Korea’s new growth industries. According to the report, the industries are next-generation semiconductor, display, EV, re
Samsung Group has invested in Jaguar Gene Therapy of the United States to discover innovative technologies and secure competitiveness in the rapidly growing gene therapy market.The investment was made by a venture investment fund (SVIC No. 54 New Technology Business Investment) established in August
Samsung C&T and Samsung Electronics, major shareholders of Samsung Biologics, will jointly make a two-trillion-won equity investment in the biotech subsidiary.The two companies participated in Samsung Biologics' paid-in capital increase of 3.2 trillion won. Samsung Biologics is increasing its ca
The author is an analyst of NH Investment & Securities. He can be reached at pk.park@nhqv.co. -- Ed. In the global market, valuation multiples for the medical device sector are higher than those of the pharmaceutical arena. In the domestic market, however, the situation is opposite. We expect re-rat
KT announced on March 16 that it has signed a strategic business agreement with MenuTalk, a company specializing in an unmanned ordering platform, to promote the use of artificial intelligence (AI)-powered service robots.MenuTalk is a company that develops solutions and IoT software for restaurants.
Chong Kun Dang Bio announced on March 10 that it has recently signed a contract manufacturing organization (CMO) contract with biotech startup EnhancedBio for production of the key material for engineered ionizable lipid nanoparticle (EN-LNP) technology.EN-LNP is a technology for targeted delivery o
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association announced on March 2 that South Korean biotech and pharmaceutical companies exported 32 technologies equivalent to 13.372 trillion won last year. For reference, the latter was 1.48 trillion won, 5.73 trillion won, 8.51 trillion won an
The author is an analyst of NH Investment & Securities. He can be reached at pk.park@nhqv.co. -- Ed. In February, the m-m fall in major NYSE bio indices narrowed versus the January figures. We view overweighting within IBB on leading new drug companies such as Amgen and Vertex Pharma as being a sign
The author is an analyst of KB Securities. He can be reached at kimtaehee@kbfg.com. -- Ed. Maintain BUY, lower target price from KRW86,000 to KRW75,000 We lower our TP on Yuhan Corp. (KRW86,000→KRW75,000). We adjust WACC (7.49%→7.76%), risk-free rate (1.02%→1.29%) and market risk premium (7.36%→7.16
Incheon City Mayor Park Nam-chun took office in July 2018. Since then, the city has accelerated its growth as a hub of Korea's future industries. The following is a recent interview with him, whose term is scheduled to end on June 30. – Ed.What would you pick as your best achievements as the may
KT will participate in this year's Mobile World Congress (MWC), which will be held for the first time in three years.KT announced on Feb. 20 that it will run an exhibition hall at MWC 2022, which will run in Barcelona, Spain, from Feb. 28 to March 3 (local time). The KT exhibition hall, formed u
The Korea Basic Science Institute (KBSI) announced on Feb. 17 that it has developed a gargle for early COVID-19 diagnosis in cooperation with Bio3S and Jeonbuk National University Hospital.Angiotensin-converting enzyme 2, where coronavirus bonding can occur, can be found in quantity in the human ora